NASDAQ · RKDA

Arcadia Biosciences, Inc.

$0.64 +$0.02 (+2.89%) 1D Market open

Key Metrics

$1.36M
Market cap
P/E · TTM
−$100.00K
Revenue · TTM
−$6.98M
Net income
EPS · TTM $-5.11
Dividend yield
Free cash flow
Beta · 1Y 1.18
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    Money has been moving into its sector (Energy).

    Energy has run +9.0 points vs SPY over four weeks, ranking 10→1→1→1 of 11 sectors — this stock trades inside that current.

    RECEIPT: ROTATION MAP, LIVE ↗
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 14
    From its Mar 9 high, the share price fell 71%.

    Peak close $2.16 on Mar 9; trough close $0.62 on Jul 14. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -71%
  • Jun 11
    The stock moved +18.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 11
  • Jun 8
    The stock moved -13.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 8

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.36M
Enterprise value
Shares outstanding2.2M
52-wk range$0.59 – $6.71
Avg volume · 20D237.5K
Net cash
Book value / share$2.11
IndustryCrude Petroleum & Natural Gas
ExchangeNASDAQ
About Arcadia Biosciences, Inc.
IPO dateMay 15, 2015
Employees8

Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating 1,309.0%
Net 6,984.0%
FCF
ROE / ROIC -242.1% · —

Financial Health

Current ratio3.79
Quick ratio3.17
Debt / equity
Debt / EBITDA
Net cash
Working capital$3.80M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

-74.8
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings